Vetbiolix
Investors

Our investors

Vetbiolix has raised more than 7 million Euros since its creation thanks to the support of VC investors specializing in disruptive innovation in the life sciences.

Captech Santé

VC-fund specialized in Seed to Serie A investments in Biotech, Medtech, e-Health et Nutrition. Launched in early 2022 with €26 million under management, the fund’s mission is to support high-potential deeptech start-ups at the crossroads of scientific research and industrial innovation.

Nord France Amorçage

Created in 2013, Nord France Amorçage (NFA) is a €50 million fund dedicated to financing innovative companies in the Hauts-de-France region. Wholly owned by the Hauts-de-France Region, the fund leverages €34 million in ERDF (European Regional Development Fund) funding to invest in equity alongside high-potential startups and young companies in the region. The fund is managed by the Siparex Group, a leading independent private equity firm in France.

TUDIGO

Tudigo is a crowdfunding platform that connects impact project leaders with investors who can invest from 1,000 euros. To date: 178 M€ invested regrouping 18 000 committed investors.

Eurasanté

Eurasanté is a development agency (Lille, FRANCE) dedicated to tech transfer and business development in the life sciences sector. For thirty years, Eurasanté has worked to promote the development of the nutrition & health sector in all its dimensions. Our experienced project managers assist researchers, startups, and businesses to develop their innovations and projects, boosting their business and networks. It leads 4 campuses of excellence in Hauts-de-France region.

BPI France

Since 2013, Bpifrance has become the one stop shop for entrepreneurs with a vastly comprehensive toolbox offered in the field to customers through 50 local branches. Our mission is simple: we believe in serving the future, by being entrepreneur-centric and heavily decentralized. € 17,32 Bn direct funding / € 8,2 Bn of guaranteed bank loans / € 4,47 Bn of investment.

L’Europe s’engage en France

The European Social Fund Plus (ESF+) is the European Union’s (EU) main instrument for investing in human capital and supporting the implementation of the European Pillar of Social Rights, with a budget of €142.7 billion for the period 2021-2027.

Vetbiolix Investors